⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Class Action Announcement for Ultragenyx Pharmaceutical Inc. (RARE): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Ultragenyx Pharmaceutical Inc.
globenewswire.com
RARE
April 6, 2026 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against RARE
globenewswire.com
RARE
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit Filed; Lead Plaintiff Deadline April 6, 2026 – RGRD Law
globenewswire.com
RARE
RARE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
prnewswire.com
RARE
Levi & Korsinsky Notifies Shareholders of Ultragenyx Pharmaceutical Inc.(RARE) of a Class Action Lawsuit and an Upcoming Deadline
prnewswire.com
RARE
RARE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RARE
Pomerantz LLP Advises of Securities Class Action Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
accessnewswire.com
RARE